219 related articles for article (PubMed ID: 30284368)
1. Quality of life: fractionated stereotactic radiotherapy versus enucleation treatment in uveal melanoma patients.
van Beek JGM; Buitendijk GHS; Timman R; Muller K; Luyten GPM; Paridaens D; Naus NC; Kiliç E
Acta Ophthalmol; 2018 Dec; 96(8):841-848. PubMed ID: 30284368
[TBL] [Abstract][Full Text] [Related]
2. Quality of life in the follow-up of uveal melanoma patients after enucleation in comparison to CyberKnife treatment.
Klingenstein A; Fürweger C; Mühlhofer AK; Leicht SF; Schaller UC; Muacevic A; Wowra B; Hintschich C; Eibl KH
Graefes Arch Clin Exp Ophthalmol; 2016 May; 254(5):1005-12. PubMed ID: 26573389
[TBL] [Abstract][Full Text] [Related]
3. Psychological reactions and quality of life in patients with posterior uveal melanoma treated with ruthenium plaque therapy or enucleation: a one year follow-up study.
Brandberg Y; Kock E; Oskar K; af Trampe E; Seregard S
Eye (Lond); 2000 Dec; 14(Pt 6):839-46. PubMed ID: 11584839
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic Radiosurgery and Fractionated Stereotactic Radiation Therapy for the Treatment of Uveal Melanoma.
Yazici G; Kiratli H; Ozyigit G; Sari SY; Cengiz M; Tarlan B; Mocan BO; Zorlu F
Int J Radiat Oncol Biol Phys; 2017 May; 98(1):152-158. PubMed ID: 28586956
[TBL] [Abstract][Full Text] [Related]
5. Risk factors associated with secondary enucleation after fractionated stereotactic radiotherapy in uveal melanoma.
van den Bosch T; Vaarwater J; Verdijk R; Muller K; Kiliç E; Paridaens D; de Klein A; Naus N
Acta Ophthalmol; 2015 Sep; 93(6):555-60. PubMed ID: 25879399
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic radiosurgery and fractionated stereotactic radiotherapy in the treatment of uveal melanoma.
Henderson MA; Shirazi H; Lo SS; Mendonca MS; Fakiris AJ; Witt TC; Worth RM; Timmerman RD
Technol Cancer Res Treat; 2006 Aug; 5(4):411-9. PubMed ID: 16866571
[TBL] [Abstract][Full Text] [Related]
7. Fractionated stereotactic radiotherapy for uveal melanoma, late clinical results.
Muller K; Naus N; Nowak PJ; Schmitz PI; de Pan C; van Santen CA; Marijnissen JP; Paridaens DA; Levendag PC; Luyten GP
Radiother Oncol; 2012 Feb; 102(2):219-24. PubMed ID: 21864922
[TBL] [Abstract][Full Text] [Related]
8. Linear accelerator-based stereotactic fractionated photon radiotherapy as an eye-conserving treatment for uveal melanoma.
Akbaba S; Foerster R; Nicolay NH; Arians N; Bostel T; Debus J; Hauswald H
Radiat Oncol; 2018 Aug; 13(1):140. PubMed ID: 30071857
[TBL] [Abstract][Full Text] [Related]
9. Quality of life after iodine 125 brachytherapy vs enucleation for choroidal melanoma: 5-year results from the Collaborative Ocular Melanoma Study: COMS QOLS Report No. 3.
Melia M; Moy CS; Reynolds SM; Hayman JA; Murray TG; Hovland KR; Earle JD; Kurinij N; Dong LM; Miskala PH; Fountain C; Cella D; Mangione CM;
Arch Ophthalmol; 2006 Feb; 124(2):226-38. PubMed ID: 16476893
[TBL] [Abstract][Full Text] [Related]
10. Comparison between patient-reported outcomes after enucleation and proton beam radiotherapy for uveal melanomas: a 2-year cohort study.
Hope-Stone L; Brown SL; Heimann H; Damato B
Eye (Lond); 2019 Sep; 33(9):1478-1484. PubMed ID: 30988421
[TBL] [Abstract][Full Text] [Related]
11. Quality of life in the follow-up of uveal melanoma patients after CyberKnife treatment.
Klingenstein A; Fürweger C; Nentwich MM; Schaller UC; Foerster PI; Wowra B; Muacevic A; Eibl KH
Melanoma Res; 2013 Dec; 23(6):481-8. PubMed ID: 24048223
[TBL] [Abstract][Full Text] [Related]
12. [Psychological aspects and quality of life in uveal melanoma patients during the treatment process by ocular bulb remotion].
Amaro TA; Yazigi L; Erwenne C
Arq Bras Oftalmol; 2006; 69(6):889-94. PubMed ID: 17273685
[TBL] [Abstract][Full Text] [Related]
13. No demonstrated effect of pre-enucleation irradiation on survival of patients with uveal melanoma.
Luyten GP; Mooy CM; Eijkenboom WM; Stijnen T; Hellemons LP; Luider TM; de Jong PT
Am J Ophthalmol; 1995 Jun; 119(6):786-91. PubMed ID: 7785695
[TBL] [Abstract][Full Text] [Related]
14. Influence of uveal melanoma therapy on patients' quality of life: a psychological study.
Chabert S; Velikay-Parel M; Zehetmayer M
Acta Ophthalmol Scand; 2004 Feb; 82(1):25-31. PubMed ID: 14982042
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of treatment with stereotactic radiosurgery or proton beam therapy for choroidal melanoma.
Sikuade MJ; Salvi S; Rundle PA; Errington DG; Kacperek A; Rennie IG
Eye (Lond); 2015 Sep; 29(9):1194-8. PubMed ID: 26160531
[TBL] [Abstract][Full Text] [Related]
16. Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation.
Krohn J; Monge OR; Skorpen TN; Mørk SJ; Dahl O
Eye (Lond); 2008 Nov; 22(11):1398-403. PubMed ID: 17585309
[TBL] [Abstract][Full Text] [Related]
17. Patient-reported Outcomes and Quality of Life After Treatment of Choroidal Melanoma: A Comparison of Enucleation Versus Radiotherapy in 1596 Patients.
Damato B; Hope-Stone L; Cooper B; Brown SL; Salmon P; Heimann H; Dunn LB
Am J Ophthalmol; 2018 Sep; 193():230-251. PubMed ID: 29555484
[TBL] [Abstract][Full Text] [Related]
18. No differences in outcome between radical surgical treatment (enucleation) and stereotactic radiosurgery in patients with posterior uveal melanoma.
Furdova A; Slezak P; Chorvath M; Waczulikova I; Sramka M; Kralik G
Neoplasma; 2010; 57(4):377-81. PubMed ID: 20429631
[TBL] [Abstract][Full Text] [Related]
19. Phantom Eye Syndrome: Patient Experiences after Enucleation for Uveal Melanoma.
Hope-Stone L; Brown SL; Heimann H; Damato B; Salmon P
Ophthalmology; 2015 Aug; 122(8):1585-90. PubMed ID: 26004080
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of fractionated stereotactic radiotherapy for uveal melanoma.
Muller K; Nowak PJ; de Pan C; Marijnissen JP; Paridaens DA; Levendag P; Luyten GP
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):116-22. PubMed ID: 16111579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
